Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2000
03/09/2000DE19837230A1 Use of neurotrophin-4 as a therapeutic agent, especially for treating melanoma
03/09/2000DE19818680C1 A DNA double strand break repair protein, Nibrin, and related DNA useful for diagnosis and therapy of Nijmegen Breakage Syndrome and other diseases influenced by DNA-double-strand break repair
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000CA2342205A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000CA2341775A1 Inducible expression system
03/09/2000CA2341754A1 Stem cells bearing an fgf receptor on the cell surface
03/09/2000CA2341705A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000CA2341578A1 Phosphoepoxides, method for making same and uses
03/09/2000CA2341522A1 Novel pharmaceutical salt form
03/09/2000CA2341518A1 Hypoxia regulated genes
03/09/2000CA2341412A1 Rationally designed heparinases derived from heparinase i and ii
03/09/2000CA2341409A1 Novel angiogenesis inhibitors
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2341142A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers
03/09/2000CA2341064A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000CA2340865A1 High-affinity antibodies
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2340592A1 Phelix: a testis-specific protein expressed in cancer
03/09/2000CA2340326A1 Cytotoxic peptides modified by bulky or lipophilic moieties
03/09/2000CA2340325A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000CA2339947A1 Method of mitigating the adverse effects of interleukin-2
03/09/2000CA2249657A1 Novel compounds
03/08/2000EP0983992A2 Compounds having selectivity for retinoid x receptors
03/08/2000EP0983991A2 Compounds having selectivity for retinoid x receptors
03/08/2000EP0983359A1 DETECTION OF LOSS OF THE WILD-TYPE $i(hu)BUB1 GENE
03/08/2000EP0983358A1 New human dp1 homolog
03/08/2000EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
03/08/2000EP0983353A1 Methods and compositions for diagnosis and treatment of cancer
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983295A2 4-aza-steroids substituted in one or more of positions 7, 11 and 15 or with an unsaturated 14(15)-double bond as inhibitors of testosterone-5-alpha-reductase
03/08/2000EP0983273A1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents
03/08/2000EP0983272A1 A new class of benzoporphyrin derivative photoactive compounds
03/08/2000EP0983270A1 PROCESS FOR PREPARING 6-$i(O)-MONOESTERS OF CASTANOSPERMINE
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983248A1 Analogs of duocarmycin and cc-1065
03/08/2000EP0983241A1 Cyanoguanidines as cell proliferation inhibitors
03/08/2000EP0983234A1 Leukotriene b 4? derivatives, in particular 7-methylcyclohexyl-ltb 4? antagonists
03/08/2000EP0983229A1 Metalloproteinase inhibitors
03/08/2000EP0983221A1 Cyclohexanediol derivatives
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0983072A1 Fructan containing composition for the prevention and treatment of colon cancer
03/08/2000EP0983063A1 Pharmaceutical composition containing uscharidin or its analogues
03/08/2000EP0982991A1 Beta lactams as antiproliferative agents
03/08/2000EP0871655B1 Pcna binding substance
03/08/2000EP0804596A4 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
03/08/2000EP0591355B1 Porphycene compounds for photodynamic therapy
03/08/2000CN1246862A Epothilone analogs
03/08/2000CN1246857A Substituted pyrimidinone and pyridinone compounds and their use
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246791A Compositions and methods for treating or preventing inflammatory diseases
03/08/2000CN1246475A Corticotropin release factors antagonistic agent
03/08/2000CN1246358A Medical capsule for treating cerebroma and its preparing process
03/08/2000CN1246346A Medicine for treating cancer and its preparing technology
03/08/2000CN1246343A Snuff for treating mastopathy and its inhalator
03/07/2000US6034267 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
03/07/2000US6034246 Anticancer agent
03/07/2000US6034244 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
03/07/2000US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists
03/07/2000US6034136 Certain cyclic thio substituted acylaminoacid amide derivatives
03/07/2000US6034092 2-[2-[(2-hydroxyethyl)amino]ethy [l]-5-[[2-methylamino)ethyl]amino]indazolo4,3-gh]isoquinolin-6(2H)-one as antitumor agent
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000US6034072 Genetic engineering; anticancer, antitumor agent
03/07/2000US6034065 Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10
03/07/2000US6034063 Human phosphatidylinositol transfer protein gamma
03/07/2000US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
03/07/2000US6033876 The antibodies may be used for diagnosis, or conjugated to a toxin to produce an immunotoxin.
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033856 Promoter of the cdc25B gene, its preparation and use
03/07/2000US6033847 InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
03/07/2000US6033669 Methods for generating cytotoxic T cells and treatment of diseases thereby
03/07/2000CA2195093C Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
03/07/2000CA2013966C Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins
03/07/2000CA2007935C Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
03/02/2000WO2000011478A1 Assays, methods and means for modulating nuclear localisation
03/02/2000WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS
03/02/2000WO2000011201A1 Targeted alphavirus and alphaviral vectors
03/02/2000WO2000011195A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000WO2000011194A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011169A2 Human cell signaling proteins (csig)
03/02/2000WO2000011166A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000WO2000011160A1 Grip, human adapter protein related to the grb2 family member
03/02/2000WO2000011033A2 Expression and export of angiostatin and endostatin as immunofusins
03/02/2000WO2000011015A1 Secreted proteins and polynucleotides encoding them
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010988A1 Water soluble analogs and prodrugs of paclitaxel
03/02/2000WO2000010981A1 Quinazoline derivatives
03/02/2000WO2000010958A1 Vitamin d3 mimics
03/02/2000WO2000010612A1 Methods to enhance and confine expression of genes
03/02/2000WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000WO2000010602A1 Lats knock-out animal models and their uses
03/02/2000WO2000010600A2 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents
03/02/2000WO2000010597A1 Vaccine comprising cytokine-induced heat shock proteins (hsp)
03/02/2000WO2000010590A2 Cancer treatment
1 ... 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 ... 2211